Cargando…

Comparative effectiveness of oral anticoagulants in everyday practice

OBJECTIVES: This study evaluated the comparative effectiveness of vitamin K antagonists (VKAs), direct thrombin inhibitors (DTIs) and factor Xa inhibitors (FXaI) in patients with atrial fibrillation (AF) at risk of stroke in everyday practice. METHODS: Data from patients with AF and Congestive heart...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camm, A John, Fox, Keith A A, Virdone, Saverio, Bassand, Jean-Pierre, Fitzmaurice, David A, Berchuck, Samuel I, Gersh, Bernard J, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Misselwitz, Frank, Pieper, Karen S, Turpie, Alexander G G, Verheugt, Freek W A, Cappato, Riccardo, Kakkar, Ajay K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Arrhythmias and Sudden Death
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165153/ https://www.ncbi.nlm.nih.gov/pubmed/33593994 http://dx.doi.org/10.1136/heartjnl-2020-318420

Ejemplares similares

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants
por: Camm, A John, et al.
Publicado: (2018)

Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillation
por: Melduni, Rowlens M, et al.
Publicado: (2020)

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022)

Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study)
por: Vinereanu, Dragos, et al.
Publicado: (2020)

Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
por: Serebruany, Victor, et al.
Publicado: (2017)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

External validation and updating of prediction models of bleeding risk in patients with cancer receiving anticoagulants
por: Trinks-Roerdink, EM, et al.
Publicado: (2023)

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018)

Anticoagulation trends in adults aged 65 years and over with atrial fibrillation: a cohort study
por: Lund, Jenny, et al.
Publicado: (2021)

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
por: Friberg, Leif, et al.
Publicado: (2017)

Twelve-month outcome in patients with stroke and atrial fibrillation not suitable to oral anticoagulant strategy: the WATCH-AF registry
por: Guidoux, Celine, et al.
Publicado: (2019)

Heart rate is associated with progression of atrial fibrillation, independent of rhythm
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease
por: Batra, Gorav, et al.
Publicado: (2022)

Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis
por: Grymonprez, Maxim, et al.
Publicado: (2020)

Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term vitamin K antagonist treatment to dabigatran
por: Choi, Eue-Keun, et al.
Publicado: (2020)

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
por: Pol, Tymon, et al.
Publicado: (2021)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

Role of artificial intelligence in defibrillators: a narrative review
por: Brown, Grace, et al.
Publicado: (2022)

Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registry
por: Blom, M T, et al.
Publicado: (2014)

Low incidence of left atrial delayed enhancement with MRI in patients with AF: a single-centre experience
por: Bois, John P, et al.
Publicado: (2017)

Modifiable risk factors predict incident atrial fibrillation and heart failure
por: Wong, Jorge A, et al.
Publicado: (2020)

Internationally validated score to predict the outcome of non-paroxysmal atrial fibrillation ablation: the ‘FLAME score’
por: Boyalla, Vennela, et al.
Publicado: (2021)

Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy
por: Vijapurapu, Ravi, et al.
Publicado: (2019)

Opportunistic detection of atrial fibrillation using blood pressure monitors: a systematic review
por: Kane, Sarah A, et al.
Publicado: (2016)

Shift work is associated with 10-year incidence of atrial fibrillation in younger but not older individuals from the general population: results from the Tromsø Study
por: Zwartkruis, Victor W, et al.
Publicado: (2022)

Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis
por: Emanuel, Subo, et al.
Publicado: (2023)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

Discovery of predictors of sudden cardiac arrest in diabetes: rationale and outline of the RESCUED (REcognition of Sudden Cardiac arrest vUlnErability in Diabetes) project
por: van Dongen, Laura H, et al.
Publicado: (2021)

A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation?
por: Ezzat, Vivienne A, et al.
Publicado: (2015)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Individual-level income and out-of-hospital cardiac arrest survival in men and women
por: van Dongen, Laura H, et al.
Publicado: (2022)

Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies
por: Fradley, Michael G, et al.
Publicado: (2017)

Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010
por: Tiwari, Sweta, et al.
Publicado: (2015)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Comparison of three current sets of electrocardiographic interpretation criteria for use in screening athletes
por: Riding, Nathan R, et al.
Publicado: (2015)

Implantable loop recorders in patients with heart disease: comparison between patients with and without syncope
por: Assaf, Amira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ouabi47i61vsu0q2svbg7vjkg1